US Stock MarketDetailed Quotes

QNCX Quince Therapeutics

Watchlist
  • 1.900
  • +0.310+19.50%
Close Nov 14 16:00 ET
  • 1.939
  • +0.039+2.05%
Pre 08:37 ET
83.60MMarket Cap-1532P/E (TTM)

Quince Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
58.35%8.84M
22.92%8.67M
-46.98%27.14M
32.03%8.34M
-10.32%6.09M
-65.65%5.58M
-67.73%7.06M
-43.32%51.19M
-73.16%6.32M
-68.65%6.8M
Selling and administrative expenses
10.97%4.7M
29.93%4.97M
-31.97%17.7M
38.24%4.91M
7.34%4.66M
-53.30%4.23M
-57.98%3.83M
-11.89%26.01M
-57.38%3.55M
-43.13%4.34M
-General and administrative expense
10.97%4.7M
29.93%4.97M
-31.97%17.7M
38.24%4.91M
7.34%4.66M
-53.30%4.23M
-57.98%3.83M
-11.89%26.01M
-57.38%3.55M
-43.13%4.34M
Research and development costs
206.50%4.15M
14.61%3.7M
-62.48%9.45M
24.06%3.43M
-41.62%1.43M
-81.21%1.35M
-74.68%3.23M
-58.59%25.18M
-81.81%2.77M
-82.54%2.45M
Operating profit
-58.35%-8.84M
-22.92%-8.67M
46.98%-27.14M
-32.03%-8.34M
10.32%-6.09M
65.65%-5.58M
67.73%-7.06M
43.32%-51.19M
73.16%-6.32M
68.65%-6.8M
Net non-operating interest income expense
2.24%823K
26.71%887K
225.66%3.48M
89.18%1.01M
204.44%959K
455.17%805K
872.22%700K
72.26%1.07M
410.48%536K
146.09%315K
Non-operating interest income
2.24%823K
26.71%887K
225.66%3.48M
89.18%1.01M
204.44%959K
455.17%805K
872.22%700K
72.26%1.07M
410.48%536K
146.09%315K
Other net income (expense)
-18,286.92%-19.67M
45.79%-3.33M
-334.58%-7.92M
-708.03%-1.51M
85.01%-216K
85.44%-107K
-4,197.33%-6.15M
-637.65%-1.82M
522.50%249K
-817.83%-1.44M
Special income (charges)
---19.35M
56.86%-2.55M
-806.42%-7.48M
---1.58M
--0
--0
---5.9M
---825K
--0
---825K
-Less：Restructuring and merger&acquisition
--2.22M
--2.55M
--1.58M
----
----
--0
--0
--0
----
----
-Less:Impairment of capital assets
--17.13M
--0
615.15%5.9M
--0
--0
--0
--5.9M
--825K
--0
--825K
Other non- operating income (expenses)
-202.80%-324K
-219.92%-787K
55.87%-440K
-74.30%64K
64.94%-216K
85.44%-107K
-264.00%-246K
-303.64%-997K
522.50%249K
-292.36%-616K
Income before tax
-466.78%-27.69M
11.07%-11.12M
39.20%-31.58M
-59.79%-8.84M
32.45%-5.35M
71.00%-4.89M
42.23%-12.5M
42.25%-51.94M
76.35%-5.53M
63.51%-7.92M
Income tax
36K
112.50%31K
30.63%-197K
51K
0
0
-248K
-284K
0
0
Net income
-467.52%-27.73M
9.02%-11.15M
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
Net income continuous Operations
-467.52%-27.73M
9.02%-11.15M
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
Minority interest income
Net income attributable to the parent company
-467.52%-27.73M
9.02%-11.15M
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-467.52%-27.73M
9.02%-11.15M
39.25%-31.39M
-60.72%-8.89M
32.45%-5.35M
70.50%-4.89M
43.38%-12.25M
42.56%-51.66M
76.35%-5.53M
63.51%-7.92M
Basic earnings per share
-357.14%-0.64
23.53%-0.26
45.45%-0.84
-61.54%-0.21
31.82%-0.15
72.55%-0.14
52.78%-0.34
49.17%-1.54
83.33%-0.13
69.86%-0.22
Diluted earnings per share
-357.14%-0.64
23.53%-0.26
45.45%-0.84
-61.54%-0.21
31.82%-0.15
72.55%-0.14
52.78%-0.34
49.17%-1.54
83.33%-0.13
69.86%-0.22
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024 (Q1)Mar 31, 2024 (FY)Dec 31, 2023 (Q4)Dec 31, 2023 (Q3)Sep 30, 2023 (Q2)Jun 30, 2023 (Q1)Mar 31, 2023 (FY)Dec 31, 2022 (Q4)Dec 31, 2022 (Q3)Sep 30, 2022
Total revenue 0 0 0 0 0 0 0 0 0 0
Operating revenue --0 --0 --0 --0 --0 --0 --0 --0 --0 --0
Cost of revenue
Gross profit
Operating expense 58.35%8.84M 22.92%8.67M -46.98%27.14M 32.03%8.34M -10.32%6.09M -65.65%5.58M -67.73%7.06M -43.32%51.19M -73.16%6.32M -68.65%6.8M
Selling and administrative expenses 10.97%4.7M 29.93%4.97M -31.97%17.7M 38.24%4.91M 7.34%4.66M -53.30%4.23M -57.98%3.83M -11.89%26.01M -57.38%3.55M -43.13%4.34M
-General and administrative expense 10.97%4.7M 29.93%4.97M -31.97%17.7M 38.24%4.91M 7.34%4.66M -53.30%4.23M -57.98%3.83M -11.89%26.01M -57.38%3.55M -43.13%4.34M
Research and development costs 206.50%4.15M 14.61%3.7M -62.48%9.45M 24.06%3.43M -41.62%1.43M -81.21%1.35M -74.68%3.23M -58.59%25.18M -81.81%2.77M -82.54%2.45M
Operating profit -58.35%-8.84M -22.92%-8.67M 46.98%-27.14M -32.03%-8.34M 10.32%-6.09M 65.65%-5.58M 67.73%-7.06M 43.32%-51.19M 73.16%-6.32M 68.65%-6.8M
Net non-operating interest income expense 2.24%823K 26.71%887K 225.66%3.48M 89.18%1.01M 204.44%959K 455.17%805K 872.22%700K 72.26%1.07M 410.48%536K 146.09%315K
Non-operating interest income 2.24%823K 26.71%887K 225.66%3.48M 89.18%1.01M 204.44%959K 455.17%805K 872.22%700K 72.26%1.07M 410.48%536K 146.09%315K
Other net income (expense) -18,286.92%-19.67M 45.79%-3.33M -334.58%-7.92M -708.03%-1.51M 85.01%-216K 85.44%-107K -4,197.33%-6.15M -637.65%-1.82M 522.50%249K -817.83%-1.44M
Special income (charges) ---19.35M 56.86%-2.55M -806.42%-7.48M ---1.58M --0 --0 ---5.9M ---825K --0 ---825K
-Less：Restructuring and merger&acquisition --2.22M --2.55M --1.58M ---- ---- --0 --0 --0 ---- ----
-Less:Impairment of capital assets --17.13M --0 615.15%5.9M --0 --0 --0 --5.9M --825K --0 --825K
Other non- operating income (expenses) -202.80%-324K -219.92%-787K 55.87%-440K -74.30%64K 64.94%-216K 85.44%-107K -264.00%-246K -303.64%-997K 522.50%249K -292.36%-616K
Income before tax -466.78%-27.69M 11.07%-11.12M 39.20%-31.58M -59.79%-8.84M 32.45%-5.35M 71.00%-4.89M 42.23%-12.5M 42.25%-51.94M 76.35%-5.53M 63.51%-7.92M
Income tax 36K 112.50%31K 30.63%-197K 51K 0 0 -248K -284K 0 0
Net income -467.52%-27.73M 9.02%-11.15M 39.25%-31.39M -60.72%-8.89M 32.45%-5.35M 70.50%-4.89M 43.38%-12.25M 42.56%-51.66M 76.35%-5.53M 63.51%-7.92M
Net income continuous Operations -467.52%-27.73M 9.02%-11.15M 39.25%-31.39M -60.72%-8.89M 32.45%-5.35M 70.50%-4.89M 43.38%-12.25M 42.56%-51.66M 76.35%-5.53M 63.51%-7.92M
Minority interest income
Net income attributable to the parent company -467.52%-27.73M 9.02%-11.15M 39.25%-31.39M -60.72%-8.89M 32.45%-5.35M 70.50%-4.89M 43.38%-12.25M 42.56%-51.66M 76.35%-5.53M 63.51%-7.92M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -467.52%-27.73M 9.02%-11.15M 39.25%-31.39M -60.72%-8.89M 32.45%-5.35M 70.50%-4.89M 43.38%-12.25M 42.56%-51.66M 76.35%-5.53M 63.51%-7.92M
Basic earnings per share -357.14%-0.64 23.53%-0.26 45.45%-0.84 -61.54%-0.21 31.82%-0.15 72.55%-0.14 52.78%-0.34 49.17%-1.54 83.33%-0.13 69.86%-0.22
Diluted earnings per share -357.14%-0.64 23.53%-0.26 45.45%-0.84 -61.54%-0.21 31.82%-0.15 72.55%-0.14 52.78%-0.34 49.17%-1.54 83.33%-0.13 69.86%-0.22
Dividend per share
Currency Unit USD USD USD USD USD USD USD USD USD USD
Accounting Standards US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP US-GAAP
Audit Opinions -- -- Unqualified Opinion -- -- -- -- Unqualified Opinion -- --

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data

Concept Top Gainers Yesterday
Top Gainers Yesterday
Intraday-2.44%